Indian pharmaceuticals firm Biocon Ltd. will buy out minority shareholders in Biocon Biologics Ltd. via a mix of cash and shares in a deal that values the biosimilars unit at $5.5 billion.
www.bloomberg.com
#Biocon #Moves #Fully #Biologics #Unit #Valued #Billion
Biocon Moves to Fully Own Biologics Unit Valued at $5.5 Billion
